The interactions between various miRNAs and complex signaling pathways during the process of third-generation EGFR-TKIs resistance in lung tumor cells are summarized above, paving the way for the introduction of miRNA-based biomarkers to detect the third-generation EGFR-TKIs response in lung cancer patients. The gene discussed is EGFR; the disease is lung carcinoma.